Explore 3 Stock Ideas & Industry Insights Download Free Report

blue-chip

Growth Moderation and Competitive Pressures Temper BSX’s Near-Term Outlook

Aug 18, 2026 | Team Kalkine
Growth Moderation and Competitive Pressures Temper BSX’s Near-Term Outlook
Image source: Shutterstock

  • BSX:NYSE
  • Investment Type
    Large-cap
  • Risk Level
  • Action
  • Rec. Price (US$)

Boston Scientific Corporation (NYSE: BSX) is a leading global medical technology company that develops and manufactures innovative devices for cardiovascular, electrophysiology, structural heart, peripheral interventions, endoscopy, urology, neuromodulation, and interventional oncology markets. The company generates revenue through the commercialization of advanced medical devices and minimally invasive therapies, supported by continuous product innovation, strategic acquisitions, and a broad global distribution network serving hospitals, physicians, and healthcare providers worldwide.

As per US The Shariah Compliance Report published on ‘BSX’ on Jul 10, 2026, Kalkine provided an ‘Buy’ stance on the stock at USD 45.01 based on technical analysis and the stock price has now moved up by ~ 14.26% since then and attained resistance 1 and moving towards resistance 2.

Noted below are the details of support and resistance levels provided in our previous report:


Disclaimer-

The advice given by Kalkine Canada Advisory Services Inc. and provided on this website is general information only and it does not take into account your investment objectives, financial situation and the particular needs of any particular person. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. The website www.kalkine.ca is published by Kalkine Canada Advisory Services Inc. The link to our Terms & Conditions has been provided please go through them. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.

Past performance is not a reliable indicator of future performance.

Support

Hi! How can we help you today?

Loading…